Insight Molecular Diagnostics, Inc. (IMDX)
2.49
+0.03
(+1.22%)
USD |
NASDAQ |
Nov 06, 16:00
2.50
+0.01
(+0.40%)
After-Hours: 20:00
Insight Molecular Diagnostics Net Income (Quarterly) : -11.26M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.26M |
| March 31, 2026 | -4.29M |
| December 31, 2025 | -22.96M |
| September 30, 2025 | -10.85M |
| June 30, 2025 | -9.742M |
| March 31, 2025 | -6.671M |
| December 31, 2024 | -33.51M |
| September 30, 2024 | -13.49M |
| June 30, 2024 | -4.53M |
| March 31, 2024 | -9.129M |
| December 31, 2023 | -15.99M |
| September 30, 2023 | -6.489M |
| June 30, 2023 | -8.333M |
| March 31, 2023 | 5.129M |
| September 30, 2022 | -1.818M |
| June 30, 2022 | -1.364M |
| March 31, 2022 | -3.413M |
| December 31, 2021 | -35.88M |
| September 30, 2021 | -13.80M |
| June 30, 2021 | -10.49M |
| March 31, 2021 | -3.919M |
| Date | Value |
|---|---|
| December 31, 2020 | -6.309M |
| September 30, 2020 | -6.783M |
| June 30, 2020 | -9.108M |
| March 31, 2020 | -7.732M |
| December 31, 2019 | -7.954M |
| September 30, 2019 | -5.225M |
| June 30, 2019 | -5.383M |
| March 31, 2019 | -3.864M |
| December 31, 2018 | -4.499M |
| September 30, 2018 | -2.971M |
| June 30, 2018 | -4.505M |
| March 31, 2018 | -3.778M |
| December 31, 2017 | -3.96M |
| September 30, 2017 | -6.906M |
| June 30, 2017 | -3.804M |
| March 31, 2017 | -4.704M |
| December 31, 2016 | -3.103M |
| September 30, 2016 | -2.595M |
| June 30, 2016 | -2.543M |
| March 31, 2016 | -2.928M |
| December 31, 2015 | -3.539M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -26.98M |
| Agenus, Inc. | 1.567M |
| Amgen, Inc. | 3.864B |
| Anika Therapeutics, Inc. | -0.311M |
| BioCryst Pharmaceuticals, Inc. | 37.92M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.239M |
| Total Expenses (Quarterly) | 11.50M |
| EPS Diluted (Quarterly) | -0.3064 |
| Enterprise Value | 65.37M |
| Gross Profit Margin (Quarterly) | -202.5% |
| Profit Margin (Quarterly) | -4.71K% |
| Earnings Yield | -59.65% |
| Normalized Earnings Yield | -47.92 |